The legal status of these peptides may change as regulatory agencies evaluate additional safety and efficacy data, and providers must stay informed about current regulations and requirements
The European Food Safety Authority (EFSA) has set an adequate intake (AI) of 4.0 g/day for adults (EFSA, 2015)
9 In light of these findings, long-term use of these medications should be periodically reassessed, particularly in patients with other risk factors for vitamin B 12 deficiency
Peptide reconstitution, dosing, injection volume, and frequency depend on the exact product, pharmacy instructions, concentration, prescription label, and provider recommendations
Combining aluminum chloride with glycopyrrolate provides dual-action efficacy with limited irritation
BPC-157: 0.25-0.5 mg daily subcutaneous TB-500: Loading phase 2.5 mg twice weekly for weeks 1-4, then maintenance 2-3 mg weekly Duration: 6-8 weeks concurrent use Note: Administer separately